非洲绿猴在艾滋病研究中的应用进展

doi:10.3969/j.issn.1674-5817.2011.04.021

实验动物与比较医学 ›› 2011, Vol. 31 ›› Issue (4): 308-312.DOI: 10.3969/j.issn.1674-5817.2011.04.021

所属专题：实验动物资源开发与利用

• 综述 • 上一篇

非洲绿猴在艾滋病研究中的应用进展

邱正良¹, 杨贵波², 雷娜², 孙兆增¹, 曾林¹

1.中国人民解放军军事医学科学院实验动物中心, 北京 100071;
2.中国疾病预防控制中心性病艾滋病预防控制中心, 北京 100050

收稿日期:2011-05-16 出版日期:2011-08-25 发布日期:2011-08-25
作者简介:邱正良(1971-), 男, 副研究员, 从事实验动物科研工作
基金资助:
国家自然科学基金(30872324)资助

Progresses on Application of African Green Monkeys in AIDS Researches

QIU Zheng-liang¹, YANG Gui-Bo², LEI Na², SUN Zao-Zheng¹, ZENG Ling¹

1. Laboratory Animal center,Academy of Military Medical sciences, Beijing 100071, China;
2.National Center for AIDS/STD Control and Prevention, China CDC, Beijing 100050, China

Received:2011-05-16 Published:2011-08-25 Online:2011-08-25

摘要/Abstract

摘要： 人类在人免疫缺陷病毒(human immunodeficiency virus, HIV-1)感染后,通常经过一段潜伏期,进展为艾滋病(acquired immunodeficiency syndromes, AIDS)。非洲绿猴(African green monkeys, AGM)是SIV(simian immunodeficiency virus, SIV)的天然宿主,虽然体内的病毒水平与HIV感染者相似,但不表现出艾滋病症状。因此,探索AGM控制病毒复制和疾病进展的分子机制,可以很好地促进对HIV感染致病机理的认识和AIDS疫苗与治疗方法的研究。本文简要介绍AGM在艾滋病研究中的应用和最新研究进展,为艾滋病动物模型的研究提供更多参考。

关键词: 非洲绿猴, 猿猴类免疫缺陷病毒, 艾滋病动物模型

Abstract: Human infected with human immunodeficiency virus (HIV-1) always progress to AIDS after a variable period of latency. However, African green monkeys (AGM) with high levels of virus do not show any signs of AIDS after natural infection with simian immunodeficiency virus (SIV). This elicited interest of researchers to use AGM in studies on the cellular and molecular mechanisms to control virus replication and disease progression. In this paper, recent progresses in this field were briefly reviewed.

Key words: African green monkeys, Simian immunodeficiency virus, AIDS model

中图分类号:

Q95-33

邱正良,杨贵波,雷娜,等. 非洲绿猴在艾滋病研究中的应用进展[J]. 实验动物与比较医学, 2011, 31(4): 308-312. DOI: 10.3969/j.issn.1674-5817.2011.04.021.

QIU Zheng-liang,YANG Gui-Bo,LEI Na,et al. Progresses on Application of African Green Monkeys in AIDS Researches[J]. Laboratory Animal and Comparative Medicine, 2011, 31(4): 308-312. DOI: 10.3969/j.issn.1674-5817.2011.04.021.

参考文献

[1] Bibollet RF, Brengues C, Galat-Luong A, et al.Genetic diversity of simian immunodeficiency viruses from West African green monkeys: evidence of multiple genotypes within populations from the same geographical locale[J]. J Virol, 1997, 71:307-313.
[2] Sodora DL, Allan JS, Apetrei C, et al.Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts[J]. Nat Med, 2009, 15(8):861-865.
[3] Liovat AS, Jacquelin B, Ploquin MJ, et al.African non human primates infected by SIV - why don't they get sick? Lessons from studies on the early phase of non-pathogenic SIV infection[J]. Curr HIV Res, 2009, 7(1):39-50.
[4] Kanki PJ, Kurth R, Becker W, et al.Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera[J]. Lancet, 1985, 1(8441):1330-1332.
[5] Ohta Y, Masuda T, Tsujimoto H, et al.Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates[J]. Int J Cancer, 1988, 41:115-122.
[6] Huet T, Cheynier R, Meyerhans A, et al.Genetic organization of a chimpanzee lentivirus related to HIV-1[J]. Nature, 1990, 345:356-359.
[7] Daniel MD, Li Y, Naidu YM, et al.Simian immunodeficiency virus from African green monkeys[J]. J Virol, 1988, 62: 4123-4128.
[8] Hirsch VM, Olmsted RA, Murphey-Corb, et al.An African primate lentivirus (SIVsm) closely related to HIV-2[J]. Nature, 1989, 339: 389-392.
[9] Tsujimoto H, Hasegawa A, Maki N, et al.Sequence of a novel simian immunodeficiency virus from a wild-caught African mandrill[J]. Nature, 1989, 341: 539-541.
[10] Hirsch, VM, Dapolito GA, Goldstein S, et al. A distinct African lentivirus from Sykes' monkeys[J]. J Virol, 1993, 67: 1517-1528.
[11] Gnanadurai CW, Pandrea I, Parrish NF, et al.Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys[J]. J Virol, 2010, 84(23):12245-12254.
[12] Li Y, Naidu YM, Daniel MD, et al.Extensive genetic variability of simian immunodeficiency virus from African green monkeys[J]. J Virol, 1989, 63:1800-1802.
[13] Jubier-Maurin V, Sarni-Manchado P, Veas F, et al.Regulatory genes of simian immunodeficiency viruses from west African green monkeys (Cercopithecus aethiops sabaeus)[J]. J Virol, 1995, 69:7349-7353.
[14] Skasko M, Diamond TL, Kim B.Mechanistic variations among reverse transcriptases of simian immunodeficiency virus variants isolated from African green monkeys[J]. Biochemistry, 2009, 48(23):5389-5395.
[15] Hahn BH, Shaw GM, De Cock KM, et al.AIDS as a zoonosis: scientific and public health implications[J]. Science, 2000, 287:607-614.
[16] Paiardini M.Th17 cells in natural SIV hosts[J]. Curr Opin HIV AIDS, 2010, 5(2):166-172.
[17] Hartung S, Boller K, Cichutek K, et al.Quantitation of a lentivirus in its natural host: simian immunodeficiency virus in African green monkeys[J]. J Virol, 1992, 66:2143-2149.
[18] Pandrea I, Ribeiro RM, Gautam R, et al.Simian immunodeficiency virus SIVagm dynamics in African green monkeys[J]. J Virol, 2008, 82:3713-3724.
[19] Ennen J, Findeklee H, Dittmar MT, et al.CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine[J]. Proc Natl Acad Sci U S A, 1994, 91:7207-7211.
[20] Jacquelin B, Mayau V, Targat B, et al.Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response[J]. J Clin Invest, 2009, 119, 3544-3555.
[21] Zahn RC, Rett MD, Korioth-Schmitz B, et al.Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm[J]. J Virol, 2008, 82:11577-11588.
[22] Zahn RC, Rett MD, Li M, et al.Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease[J]. Blood,2010, 115: 3070-3078.

非洲绿猴在艾滋病研究中的应用进展

Progresses on Application of African Green Monkeys in AIDS Researches

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	焦青贞, 吴桂华, 唐雯, 樊帆, 冯凯, 杨春响, 乔建, 邓素芳. 暖通系统暂停送风下实验动物设施氨浓度的动态监测与分析[J]. 实验动物与比较医学, 2025, 45(4): 490-495.
[2]	刘文涛, 罗艳红, 龙永霞, 罗启慧, 陈正礼, 刘丽达. 四川省实验动物设施常见环境问题及检测经验[J]. 实验动物与比较医学, 2025, 45(4): 483-489.
[3]	赵鑫, 王晨曦, 石文清, 娄月芬. 斑马鱼在炎症性肠病机制及药物研究中的应用进展[J]. 实验动物与比较医学, 2025, 45(4): 422-431.
[4]	贡磊磊, 王晓霞, 封学伟, 李心蕾, 赵涵, 张雪艳, 冯欣. 不同浓度环磷酰胺诱导早发性卵巢功能不全小鼠模型及作用机制研究[J]. 实验动物与比较医学, 2025, 45(4): 403-410.
[5]	林振华, 褚祥宇, 魏振西, 董传俊, 赵增琳, 孙晓霞, 李庆雨, 张琪. 椎体成形术用于实验猪体内骨水泥安全性及有效性评价[J]. 实验动物与比较医学, 2025, 45(4): 466-472.
[6]	姜娟, 宋宁, 连文博, 邵丛丛, 顾文文, 石燕. 两种浓度乙醇溶液灌注建立小鼠宫腔粘连模型的组织病理和分子病理表型比较[J]. 实验动物与比较医学, 2025, 45(4): 393-402.
[7]	刘月琴, 薛卫国, 王淑友, 申耀华, 贾术永, 王广军, 宋晓晶. 探头式激光共聚焦成像技术用于小鼠消化道组织形态特征分析[J]. 实验动物与比较医学, 2025, 45(4): 457-465.
[8]	郑卿勇, 杨冬华, 马智超, 周姿余, 陆洋, 王晶宇, 邢丽娜, 康迎英, 杜莉, 赵春香, 狄宝山, 田金徽. 动物实验系统评价与Meta分析报告的规范撰写建议[J]. 实验动物与比较医学, 2025, 45(4): 496-507.
[9]	王庭君, 罗浩, 陈琦. 基于人工智能的实验动物中心信息化升级及应用实践[J]. 实验动物与比较医学, 2025, 45(4): 473-482.
[10]	王娇祥, 张璐, 陈姝含, 角德灵, 赵恒, 魏太云, 郭建雄, 徐凯祥, 魏红江. GTKO/hCD55基因编辑异种器官移植供体猪的构建及功能验证[J]. 实验动物与比较医学, 2025, 45(4): 379-392.
[11]	秦超, 李双星, 赵婷婷, 蒋晨晨, 赵晶, 杨艳伟, 林志, 王三龙, 文海若. 药物安全评价用SD大鼠90 d喂养试验的背景数据研究[J]. 实验动物与比较医学, 2025, 45(4): 439-448.
[12]	刘鹍, 兰青, 易兵, 谢晓婕. 药物非临床生殖毒性试验中动物妊娠的主要难点及应对方法[J]. 实验动物与比较医学, 2025, 45(4): 449-456.
[13]	孙强. 非动物实验替代知多少[J]. 实验动物与比较医学, 2025, 45(4): 508-514.
[14]	陈子宜, 孙红燕, 康品方, 武文娟. 肺动脉高压动物实验模型的研究进展[J]. 实验动物与比较医学, 2025, (): 1-12.
[15]	徐英韬, 王蒙蒙, 林平, 迟海涛, 王怡, 白鹰. 外泌体通过NRF2/SLC7A11/GPX4通路调控铁死亡治疗小鼠缺血性脑卒中[J]. 实验动物与比较医学, 2025, (): 1-11.